DrugCendR
La Jolla, US · Founded 2016 · California corporation
Founders & leadership
ER
Erkki RuoslahtiNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 2 rounds · 2017–2018
▶$1.1MraisedMay 2018 · 1 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMay 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erkki RuoslahtiExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $50K
- First sale
- Apr 2018
- Incorporated
- Corporation, California, 2016
- Federal exemptions
- 06b
▶$1MraisedFeb 2018 · 5 investors · BiotechnologyRule 506(b)
▶$1MraisedFeb 2018 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erkki RuoslahtiExecutive Officer
- Amount sold
- $1M
- Minimum investment
- $30K
- First sale
- Mar 2017
- Incorporated
- Corporation, California, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has DrugCendR raised?
- DrugCendR has disclosed $2.1M raised across 2 rounds.
- Where is DrugCendR headquartered?
- DrugCendR is headquartered in La Jolla, US.